DFI-105

N/A

Report date: 2025/03/07 11:49:19

Base Information

Drug NameDFI-105

Drug Alias NameDFI105DFI-105

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-CD40

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesDiabetes Free Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 2

Inactive IndicationsN/A

ATC CodeN/A